We help life sciences teams move beyond activity-based marketing plans to clear, defensible commercial strategy rooted in real market dynamics. Our work is built to support deliberate trade-offs, where to play, how to win, what to prioritize, and what to stop; across launch, in-market, and lifecycle moments.
What we do:
We build strategies that are tested against real market conditions, not internal assumptions alone. Our work integrates commercial logic, customer adoption drivers, market access realities, and execution constraints so strategy translates into measurable action.
Commercial strategy defines how a brand, asset, or portfolio will compete, grow, and create value in the market. It helps teams make better decisions about prioritization, positioning, investment, and execution.
Commercial strategy support is especially valuable before launch, during market entry planning, when portfolio priorities are shifting, or when in-market performance needs to improve.
Marketing planning often focuses on channels, tactics, and execution. Commercial strategy comes first and focuses on the core business choices that determine where to compete, how to win, and what to prioritize.
Yes. Route Consulting supports biopharma teams navigating complex market dynamics, including specialty and rare disease environments where launch readiness, differentiation, and prioritization are especially important.
Engagements may include launch strategy, portfolio prioritization, indication sequencing, market entry planning, strategic narrative development, and in-market optimization.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.